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Abstract
Background: Gastrointestinal symptoms, in particular diarrhoea, are common in non-treated HIV-1 infected individuals.
Although various enteric pathogens have been implicated, the aetiology of diarrhoea remains unexplained in a large
proportion of HIV-1 infected patients. Our aim is to identify the cause of diarrhoea for patients that remain negative in
routine diagnostics.
Methods: In this study stool samples of 196 HIV-1 infected persons, including 29 persons with diarrhoea, were
examined for enteropathogens and HIV-1. A search for unknown and unexpected viruses was performed using
virus discovery cDNA-AFLP combined with Roche-454 sequencing (VIDISCA-454).
Results: HIV-1 RNA was detected in stool of 19 patients with diarrhoea (66%) compared to 75 patients (45%)
without diarrhoea. In 19 of the 29 diarrhoea cases a known enteropathogen could be identified (66%). Next to these
known causative agents, a range of recently identified viruses was identified via VIDISCA-454: cosavirus, Aichi virus,
human gyrovirus, and non-A non-B hepatitis virus. Moreover, a novel virus was detected which was named
immunodeficiency-associated stool virus (IASvirus). However, PCR based screening for these viruses showed that
none of these novel viruses was associated with diarrhoea. Notably, among the 34% enteropathogen-negative
cases, HIV-1 RNA shedding in stool was more frequently observed (80%) compared to enteropathogen-positive
cases (47%), indicating that HIV-1 itself is the most likely candidate to be involved in diarrhoea.
Conclusion: Unexplained diarrhoea in HIV-1 infected patients is probably not caused by recently described or previously
unknown pathogens, but it is more likely that HIV-1 itself plays a role in intestinal mucosal abnormalities which leads to
diarrhoea.
Keywords: Diarrhoea, HIV-1, VIDISCA-454, Aichi virus, Human gyrovirus, Cosavirus, Immunodeficiency-associated stool
virus, NonA-nonB hepatitis virus, Norovirus, Sapovirus
Background
One of the most affected sites in untreated human im-
munodeficiency virus (HIV)-infected persons is the gastro-
intestinal tract [1-5]. In these patients diarrhoea occurs
frequently, especially in HIV-1 patients who are not treated
with anti-retroviral therapy. Routine diagnostics in fecal
samples often remain negative, despite the sensitive diag-
nostic assays which are now available. In this study our
aim is to identify the cause of diarrhoea for patients in
which no enteropathogen could be found. There are sev-
eral possible explanations why these patients remain nega-
tive in routine diagnostics: First, HIV-1 itself might play a
role. HIV-1 infected mucosal cells have been observed in
HIV-1 infected persons [6-11] and enterocytes exposed to
HIV-1 show altered function and proliferation [12,13].
However, it has not been demonstrated that HIV-1
causes diarrhoea. Secondly, there are several recent re-
ports describing novel viral agents which are found in
stool that could play a role in diarrhoea (see below), and
these agents are not yet included in routine diagnostics.
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Thirdly, an unknown or unexpected virus might be causing
diarrhoea.
One of the recently described gastrointestinal viruses
is cosavirus, which was identified in 2008 as a member
of the Picornaviridae [14]. The virus was originally found
in 2 patients with gastrointestinal infections [14,15]. How-
ever, its link with diarrhoea has not been established and a
recent study in HIV-infected individuals detected cosavirus
in a substantial number of patients without diarrhoea [16].
Aichi virus is another recently described picornavirus which
was identified in fecal samples of patients with gastroenter-
itis [17]. Several manuscripts have since then confirmed
that the virus is associated with diarrhoea [18,19], although
in one study, which included children without diarrhoea,
the association with disease could not be established since
the amount of positive samples was too low [20]. Human
gyrovirus, a member of the Circoviridae, is the most
unusual novel virus which is found in gastrointestinal
infections [21]. The virus is genetically very closely related
to gyroviruses found in chicken meat [22] and therefore it
remains uncertain whether human gyrovirus in stool is
a sign of gastrointestinal infection or a virus which is
digested with food and shed in feces, like many food
related viruses [23].
Identification of unknown and unexpected viruses is
performed via virus discovery cDNA-AFLP followed by
Roche 454 sequencing (VIDISCA-454) [24]. This technique,
which can detect single stranded and double stranded RNA
and DNA viruses [25], has been developed in our laboratory
and is a sensitive next generation sequencing-based assay
which enables detection of known and unknown viruses
in a wide range of different sample types, including stool
samples [24,26-28].
In the current study, a cohort of 196 HIV-1 infected
individuals of whom 29 suffered from severe diarrhoea
was investigated. In this patient group we determined
how many cases of diarrhoea could be explained by
known enteropathogens, recently described viruses and
unknown viruses.
Methods
Patients
One hundred and ninety-six HIV-1 infected patients, who
visited the out-patient clinic at the Amsterdam Medical
Center in 1994 and 1995, not on active antiretroviral
therapy, were asked to bring a fresh stool sample at
their next visit [29]. Criteria for inclusion in the study
were proven HIV-1 infection and being aged 18 years
or older.
Patients were asked to complete a questionnaire about
the frequency and consistency of their stools during the
week before the stool was collected. The definition of
diarrhoea was loose or watery stool at least 3 times a day
during the week prior to faeces collection (in accordance
with the WHO guidelines for diarrhoea). In addition,
patients were asked for the occurrence of additional
symptoms and use of medication that might affect the
consistency of stool. Hospital charts of patients were
reviewed for additional clinical data and the local medical
ethical committee of the AMC approved the study. Demo-
graphical data of our study population are shown in Table 1.
Cultures were performed less than 4 hours after the speci-
men was collected (see below). Blood for serum storage
and blood for CD4 cell count measurements were col-
lected at the same date as stool collection. Stool samples
were suspended in broth (1:3 dilution, Oxoid nutrient
broth no.2, pH 7.5 and 500 IU penicillin per ml, 3 μg
amphotericin B per ml). Serum and stool suspensions
were stored at −80°C until further use.
CD4 cell counts
T lymphocyte immunophenotyping for CD4 was carried
out by flow cytofluorometry. PBMC were stained with CD4
mAb (Leu-3a-PE; Becton Dickinson, Mountain View, CA)
according to the manufacturer’s protocol.
Virus diagnostics
DNA was extracted from 110 μl stool suspensions by the
Boom extraction method [31]. Reverse transcription was
performed as described [32]. Real time (RT-)PCRs specific
Table 1 Demographic data of the study population
All
(n = 196)
Diarrhoea
(n = 29)
No diarrhoea
(n = 167)
Age, mean (SD) 41 (7) 41 (7) 41 (7)
Male 93% (183) 97% (28) 93% (155)
Female 7% (13) 3% (1) 7% (12)
CD4 count,
mean (IQR)1
0.17 (0.04-0.29) 0.11 (0.01-0.20) 0.18 (0.04-0.29)
CDC stage2
1 22% (43) 9% (4) 91% (39)
2 29% (56) 13% (7) 88% (49)
3 49% (97) 19% (18) 81% (79)
Risk group
Homosexual 85% (166) 17% (28) 83% (138)
Heterosexual 11% (21) 5% (1) 95% (20)
Haemophiliac 1% (2) 0% (0) 100% (2)
Intravenous drug use 4% (7) 0% (0) 100% (7)
Blood transfusion 1% (1) 0% (0) 100% (1)
HIV-1 SI phenotype 32% (62) 21% (13) 79% (49)
P24 antigen in serum 16% (32) 3% (1) 97% (31)
HIV-1 RNA load
>4.9 × 104 copies/ml
51% (99) 19% (19) 81% (80)
1IQR = inter quartile range.
2Stage 1: symptom free, 2: AIDS related symptoms that were not AIDS
defining, 3: AIDS defining illness according to the CDC classification [30].
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for rotavirus A and C, enterovirus, human parechovirus,
norovirus genogroup I and II, astrovirus, sapovirus and
adenovirus 40, 41 and 52 was performed (see Additional
file 1: Table S1 for primer sequences) [32]. As internal
control Equine Arteritis Virus (EAV) RNA was included.
HIV-1 RNA detection in stool was determined as described
[33]. Screening for viruses which were not in the diagnostic
panel was done by PCR. Gyrovirus, Aichi virus, and non-A
non-B hepatitis virus (NANBH virus) were diagnosed
via nested PCR (see Additional file 1: Table S1 for primer
sequences). All positive signals were confirmed by Sanger
sequencing.
Stool examination for intestinal parasites
Intestinal parasites were detected in fresh stool by light
microscopy: examination of direct smears and the Ridley
concentration technique were both performed. Acid-fast
staining was performed for detection of Cryptosporidia
and Isospora species. Fluorescent staining with Uvitex 2B
(Ciba-Geigy, Basel, Switzerland) was performed for detec-
tion of Microsporidia [34].
Culture of enteropathogenic bacteria
To isolate Salmonella and Shigella species, fresh stool
specimens (within 4 hours after specimen collection) were
plated on cystine lactose electrolyte-deficient medium
(Brocalin agar; Merck, Darmstadt, Germany), Salmonella-
Shigella agar (Merck), Hektoen enteric agar (Difco, Detroit),
Rappaport medium (Difco), MacConkey agar (Becton
Dickinson, Cock-eysville, MD) and gram-negative broth
(Hajna; Difco) as enrichment. A selective cefsulodin-irga-
san-novobiocin medium (Oxoid, Basingstoke, Hampshire,
England) and a glucose broth enrichment medium were
used to isolate Yersinia species. Isolates were further
characterized by using conventional bacteriologic methods,
as outlined [35]. A cell-culture assay was used to detect
Clostridium difficile toxin [36]. The Campylobacter-selective
medium (modified Butzler medium) consisted of a solid
7% hemolyzed sheep blood–based agar (nutrient broth no.
2) with cefoperazone (30 mg/L), rifampin (10 mg/L) and
seroamphotericin B (2 mg/L) [29].
VIDISCA and Roche Titanium-454 sequencing
VIDISCA-454 was performed on 110 μl stool suspension
as previously described by De Vries et al. [25]. VIDISCA-
amplified nucleic acid - each with its own multiplex iden-
tifier (MID) - was quantified with the Quant-it dsDNA HS
Qubit kit (Invitrogen) and diluted to 106 copies/ml. All
separate fractions were pooled and 4 pools from 14 differ-
ent samples were used for a titration (DNA:beads ratio of
0.5:1, 1:1, 2:1 and 4:1) in an emulsion PCR according to
the suppliers’ protocol (LIB-A SV emPCR kit). Sequencing
was done on a 4 region GS FLX Titanium PicoTiterPlate
(70x75) with the GS FLX Titanium XLR 70 Sequencing
kit (Roche).
Sequence analysis
Primer, MID and ribosomal RNA sequences were trimmed
or removed from the reads. Sequences were assembled with
CodonCode Aligner software version 3.5.6. The consensus
sequences (contigs) and the unassembled reads were com-
pared with the available sequences in Genbank [37] via the
BlastN tool using default settings [38]. The blast output
was used to create a taxonomic classification of the reads
with Megan software version 4.70.4 [39]. The following
settings were used: Min Support: 1, Min Score: 75, Min
Score/Length: 0.75, Top Percent 100. Sequences without
homology to known sequences were compared with less
stringent settings to the available sequences in Genbank
(expect threshold: 1000, Match/Mismatch Scores: 1.-1, Gap
Costs: Existence: 2 Extension: 1), allowing more mismatches
to occur in the comparison. Subsequently, the taxonomic
classification of reads was also made with less stringent
setting (Min Support: 1, Min Score: 10, Min Score/Length:
0.00, Top Percent 100). Additional file 1: Figure S1 repre-
sents a schematic overview of our analysis method.
Statistical analysis
Statistical analysis to determine the association with diar-
rhoea was performed with the Mid-P exact test, using the
two by two table from OpenEpi [40]. Statistical analysis for
the CD4 cell counts and the HIV-1 load was performed
with the test of equality variance from OpenEpi [40].
Accession numbers
The complete genome sequence of NANBH-1 and
NANBH-2 (uncultured phage WW-nAnB strain 2 and 3)
and IAS virus have been deposited in GenBank under the
accession numbers KJ003981 – KJ003983.
Results
Known enteropathogens
To investigate how many diarrhoea cases of HIV-1 infected
individuals could be explained by infections with known
pathogens, real time PCR, bacteria culture and microscopy
was performed on stool samples of 196 HIV-1 infected
patients of whom 29 had severe diarrhoea. The known
diarrhoea agents parechovirus, astrovirus, rotavirus or
adenovirus 40, 41 or 52 were not found in any of the 196
HIV-infected patients (see Table 2). Sapovirus was found in
3 patients with diarrhoea (10%) and once in the control
group (patients without diarrhoea), whereas norovirus was
present in 10 patients with diarrhoea (34%) compared
to 13 controls (7.8%). Statistical analysis showed that
norovirus as well as sapovirus are associated with diar-
rhoea (p value: 0.0006 and 0.02 respectively). Enterovirus
was present in 3 patients with diarrhoea (10%) and in 5
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patients in the control group (3.0%), which is statistically
not significantly different.
Five patients with diarrhoea (16.8%) were infected with
bacteria: Salmonella n = 1, Mycobacterium n = 1 and
Campylobacter n = 3. On the other hand, bacteria were
also observed in 6 patients (3.6%) without diarrhoea
(Clostridium difficile n = 1 and Campylobacter n = 5).
Shigella and Yersinia were not detected in patients with or
without diarrhoea. None of the bacterial infections were
significantly associated with diarrhoea. Parasites were
found in 6 patients (21%) with diarrhoea (Cryptosporidia
n = 3, Giardia lamblia n = 1 and Microsporidia n = 2), and
in 9 patients (5.4%) of the control group without diarrhoea
(Cryptosporidia n = 1, Giardia lamblia n = 1 and
Microsporidia n = 7). Of all parasitic infections, only
Cryptosporidia was significantly associated with diarrhoea
(p = 0.02). We also screened for Cyclospora, Isospora,
worm eggs and cysts but these pathogens were not signifi-
cantly associated with diarrhoea in our study population
(data not shown).
VIDISCA-454
After screening for known viruses, bacteria and parasites,
10 patients with diarrhoea (34%) remained without diagno-
sis. We hypothesize that these patients are infected by an
unknown or unexpected viral pathogen, and therefore a
search for unknown or unexpected viruses was performed.
A total of 56 stool samples, including samples that
remained negative in diagnostics, were selected and
investigated by VIDISCA-454. Approximately 5,000 se-
quences per sample were compared with all sequences
in the non-redundant database of Genbank, using the
BLAST tool from NCBI (see Additional file 1: Figure S1).
A total of 7,316 known viral sequences could be identified
this way (2.7% of all sequences, see Table 3).
Several viruses known to cause diarrhoea were found:
sapovirus, enterovirus and norovirus (see Table 3). Fur-
thermore, new candidate diarrhoea viruses were detected:
human gyrovirus, cosavirus, and Aichi virus. In addition,
known viruses of which it is not likely that they are in-
volved in diarrhoea were detected: human adenovirus
D viruses (type 23, 45 and 51, types which are not associ-
ated with diarrhoea), JC polyoma virus (probably originat-
ing from urine [41]), hepatitis B virus, rhinovirus (probably
originating from respiratory tract) and human papilloma
viruses. Furthermore torque teno viruses (TTV) and pico-
birnaviruses were found. TTVs represent an extremely
diverse set of viruses which can differ substantially in their
genome sequence and the size of their genome. These
viruses have been detected in a large variety of clinical
samples, and their association with any disease has not
been established thus far [42]. Also picobirnaviruses are
exceptionally diverse, they have been detected in diarrhoea
patients, however, during outbreaks a diverse swarm of
picobirnaviruses is observed making it less likely that these
viruses cause diarrhoea [43].
Table 2 Prevalence of known enteropathogens
Diarrhoea
(n = 29)
Non diarrhoea
(n = 167)
P-value*
Norovirus 34% (10) 7.8% (13) 0.0006
Astrovirus 0% (0) 0% (0) -
Adenovirus 0% (0) 0% (0) -
Sapovirus 10% (3) 0.6% (1) 0.02
Enterovirus 10% (3) 3.0% (5) 0.20
Rotavirus 0% (0) 0% (0) -
Parechovirus 0% (0) 0% (0) -
HIV-1 in stool 66% (19) 45% (75) 0.06
Mycobacterium 3.4% (1) 0% (0) 0.29
Salmonella 3.4% (1) 0% (0) 0.29
Shigella 0% (0) 0% (0) -
Yersinia 0% (0) 0% (0) -
Clostridium diff 0% (0) 0.6% (1) 0.99
Campylobacter 10% (3) 3.0% (5) 0.20
Microsporidia 6.9% (2) 4.2% (7) 0.79
Giardia lamblia 3.4% (1) 0.6% (1) 0.55
Cryptosporidia 10% (3) 0.6% (1) 0.02
Pathogen negative 34% (10) 83% (139)
*P-values (Mid-P extract) in italics represent significant p-values for associating
with diarrhoea.
Table 3 Quantification of the sequence reads from virus
in stool samples of HIV-1 infected individuals
Virus: Amount of sequences:
Bacteriophages 4269
IAS virus 2201
Plant viruses 1115
Cryptosporidium parvum-virus 813
Torque teno virus 662
Norovirus 215
Sapovirus 90
Adenovirus D 84
Enterovirus 37
Cosavirus 11
NANBH-1 virus 8
JC polyomavirus 4
Human papillomavirus 4
Aichi virus 3
Hepatitis B virus 3
Picobirnavirus 3
Gyrovirus 2
Rhinovirus A 1
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Interestingly, a high amount of sequences of Crypto-
sporidium parvum-virus was found in a patient infected
with Cryptosporidium parvum. Detection of this virus in
stool of a patient never has been reported, although it has
been suggested to perform screening for the presence of
this virus in environmental samples to determine if water
is infected with the parasite [44].
Two variants of non-A non-B hepatitis virus (NANBH-1
and NANBH-2) were found. The NANBH virus has been
described in the 1980’s in patients with non A non B
hepatitis, at a time that hepatitis C virus was not identified
yet [45]. Since then no other study has investigated its
presence in humans. NANBH viruses are circular dsDNA
viruses and since the viruses were found by VIDISCA-454
in two patients with unexplained diarrhoea, their entire
genome was sequenced. The viral genomes consist of
5,005 (NANBH-1) and 5,687 (NANBH-2) bps and both
contain 4 open reading frames. The NANBH-2 virus is
similar to the NANBH-1 except for a 687 nucleotide inser-
tion in a non-coding region.
In addition, one novel virus was identified among the
VIDISCA-454 reads, which we named immunodefiency-
associated stool virus (IAS virus). The virus was present
in a high concentration in stool since large numbers of
sequence reads belonged to the virus (2201 of 7316
sequences, see Table 3 and Additional file 1: Table S2).
The complete genome sequence of IAS virus was de-
termined. This novel virus carries a dsDNA genome of
99.980 bp. The virus is exceptional because it displays
no significant similarity to any of the viruses known
thus far. Real time PCR confirmed that the virus is
present at a high load in the sample in which the virus
was discovered (1 × 107 DNA copies/ml).
In addition to mammalian or vertebrate viruses, several
bacteriophages and plant viruses were found. A total of
1,115 plant virus sequences (0.4%) and 4,269 bacterio-
phage sequences (1.6%) were identified (see Table 3 and
Additional file 1: Table S2).
Screening for novel and unexpected viruses
Among the viruses which were detected via VIDISCA-454,
there are several candidates that might be involved in the
patients’ diarrhoea. We focused on the most likely candi-
dates to be involved in intestinal malfunctioning: human
gyrovirus, cryptosporidium parvum-virus, Aichi virus and
cosavirus, together with the new IAS virus and the unex-
pected NANBH virus. For these viruses a diagnostic PCR
assay was developed (see Additional file 1: Table S1 for pri-
mer sequences). Of note, TTV and picobirnavirus, found by
VIDISCA-454, were not included in the screening. Both
virus families are extremely diverse and it is difficult, if not
impossible, to develop proper diagnostic primers that can
detect all variants. Furthermore, in literature TTVs have
not been related to gastrointestinal disease.
All 196 patients - diarrhoea patients and subjects without
diarrhoea - were tested for the abovementioned viruses.
Cosavirus was found in 1 patient (3.4%) with and in 2
patients (1.2%) without diarrhoea (see Table 4). Human
gyrovirus was detected in 33 individuals (17%): in 29
controls (17%) and 4 diarrhoea patients (14%). Also Aichi
virus was frequently found: 40 individuals (20%) were
positive of whom 34 had no diarrhoea (20%) and 6 diar-
rhoea (21%). IAS virus was detected in 2 patients with
diarrhoea (6.9%) and in 6 individuals without diarrhoea
(3.6%). The NANBH virus was detected in 2 patients with
diarrhoea (6.8%) and in 14 patients without diarrhoea
(8.4%). Thus, none of the novel or recently described
viruses could be associated with diarrhoea.
Intriguingly, detection of the IAS virus was associated
with low CD4 cell counts (p < 0.01, two-tailed t-test), and
exclusively occurred in patients with CDC-stage 2 or 3. In
contrast, detection of NANBH virus and human gyrovirus
presence was not related to CD4 cell counts, and also
occurred in the CDC-stage 1 patients (data not shown).
However, Aichi virus detection was strongly related to
CDC stage of the patient (P < 0.0001) with most patients
in CDC stage 2 or 3 being positive, however no relation
with CD4 cell counts was observed.
Cryptosporidium parvum is a parasite which causes
diarrhoea and screening for the virus which infects this
parasite can potentially be used as an additional marker,
next to the microscopic analysis for identification of the
parasite. Microscope analysis showed that 3 patients with
diarrhoea (10%) and 1 patient without diarrhoea (0.6%)
were infected with Cryptosporidium parvum. The virus in-
fecting the parasite was found in 2 patients with diarrhoea
(6.9%) and in 3 patients without diarrhoea (1.8%) and was
not associated with diarrhoea. Only one sample was found
positive in both assays.
The role of HIV-1 itself in the unexplained diarrhoea
was also examined. HIV-1 RNA was detectable in stool
of 19 patients with diarrhoea (66%) compared to 75 pa-
tients without diarrhoea (45%). This association was not
significant (p value: 0.06). It could be that HIV-1 shedding
is just a sign of infection by pathogens, and that shedding
of the virus occurs in case an enteropathogen disrupts the
mucosal barrier. However, unexpectedly, in the group
Table 4 Prevalence of new viruses
Diarrhoea
(n = 29)
Non diarrhoea
(n = 167)
P-value
IAS virus 6.9% (2) 3.6% (6) 0.67
NANBH virus 6.8% (2) 8.4% (14) 0.99
Cosavirus 3.4% (1) 1.2% (2) 0.77
Cryptosporidium parvum-virus 6.9% (2) 1.8% (3) 0.32
Human gyrovirus 14% (4) 17% (29) 0.87
Aichi virus 21% (6) 20% (34) 0.99
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without enteropathogens the frequency of HIV-1 RNA
detection in stool was higher (8 out of 10, 80%) compared
to the group where an enteropathogen could be found
(9 out of 19, 47%), thus even an inverse relationship be-
tween HIV-1 shedding and infection by known pathogens
was measured.
Finally, we could exclude that the use of antibiotics or
other treatment was the cause of diarrhoea. In total 91
patients were treated with antibiotics, most of them with
a combination of sulfamethoxazole and trimethoprim and
there was no difference in antibiotic usage in diarrhoea
cases compared to the control patients without diarrhoea
(41% versus 49%).
Discussion
Since the gastrointestinal tract is one of the most affected
sites in untreated HIV-1 infections, the cause of diarrhoea
in HIV-1 infected individuals was sought. After testing for
all known enteropathogens, a pathogenic agent was detected
in 66% of the diarrhoea cases. Virus infection accounted
for 54% of the diarrhoea cases, bacterial infection was
identified in 17%, parasitic infection in 21% and also
some dual infections were observed. Of all viruses, noro-
virus accounts for the majority of infections (34%), followed
by sapovirus and enterovirus (10% each). Still, in 34% of the
patients with diarrhoea the causative agent could not be
found. A careful investigation of the cause of unexplained
diarrhoea in these 10 patients was performed using deep
sequencing strategies. We were able to identify several
recently described and one new virus with VIDISCA-454
(e.g. NANBH virus, cosavirus, Aichi virus, human gyrovirus
and a novel IAS virus). However, no association between
these viruses and diarrhoea was observed.
Remarkably, the prevalence of Aichi virus in our study
population was 20%, while previous studies only showed a
prevalence of 0.5-1.6% [19,46]. It could be that the virus is
more frequently present in patients with immunodefi-
ciency. Furthermore, the sensitivity of our assay may also
play a part. In our study a very sensitive nested PCR assay
was used which enables detection of the virus even if it is
present at low concentrations. To exclude that the high
prevalence was caused by PCR contamination, all positive
PCR products were sequenced. Variation between the
viruses from different patients was observed, thereby
excluding contamination by a single source (see nucleotide
alignments in Additional file 1: Table S3).
Human gyrovirus was detected in 33 patients. This study
is the first study that shows that this virus was already
present in the Netherlands in 1994 and 1995. The virus
was present in 17% of the individuals without diarrhoea,
compared to 14% of the patients, indicating that it is un-
likely that the virus is involved in disease. Since antibody
response against this virus has not been described thus far,
combined with the fact that this virus was also found in
chicken [22], we hypothesize that detection of human
gyrovirus in stool may very well be food related.
Cryptosporidium parvum-virus PCR screening resulted
in 5 positive samples, but it also showed that detection of
the virus is not associated with diarrhoea. Screening for
cryptosporidium parvum-virus has already been suggested
as an alternative test to detect the parasite in surface water
[44]. However, since microscopic analysis for the parasite
itself did show a diarrhoea-association, we propose that
only screening for the Cryptosporidium parvum, and not
the virus infecting the parasite, should be performed in
diagnostics of patients.
The NANBH virus was present in some of our study
subjects in high viral loads. Recently, an Inovirus (a bacteria
infecting virus family) was described by Cantalupo et al.
[47] that resembles the NANBH virus (90% identity). This
resemblance strongly indicates that the NANBH-1 and
the NANBH-2 viruses are bacteriophages and in this re-
spect it is not surprising that no correlation with diarrhoea
was found here.
Finally, the role of HIV-1 self was investigated. Remark-
ably, although not significant, HIV-1 RNA was detected
more in stool samples in patients where no enteropathogen
could be found compared to the group with enteropatho-
gen. This result indicates that shedding of HIV-1 in feces
is not the direct result of damage to the mucosal barrier
by enteropathogens, but that HIV-1 itself may damage the
mucosal barrier and cause diarrhoea. Detection of HIV-1
in stool was not related to the stage of HIV-1 disease since
CD4 cell count, CDC stage, and HIV-1 viral load did not
differ significantly between diarrhoea patients with entero-
pathogen and people without enteropathogen (data not
shown). The relatively low number of patients with un-
explained diarrhoea is a limitation of our study. In the
future, a study focusing on unexplained diarrhoea should
include more HIV-1 positive patients with unexplained
diarrhoea to be able to confirm our hypothesis that HIV-1
itself plays a role in gastrointestinal disorders.
Conclusions
Virus discovery has in recent years revealed several previ-
ously unknown viruses for which it has been postulated
that they are involved in diarrhoea. In the study presented
here we show that infection by these novel agents does not
explain the high frequency of diarrhoea in HIV-1 infected
patients. Also the novel IAS virus could not be linked to
diarrhoea, but interestingly, it was associated with advanced
stages of HIV-1 disease. Further investigation of this virus
may reveal whether the virus is a human virus or a virus
infecting bacteria. Sequence comparison could not clarify
this, since the virus has no sequence identity to any of the
viruses known thus far.
In the early HIV-1 literature it has been shown that
HIV-1 has an effect on enterocytes. This knowledge
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combined with our detection of HIV-1 in stool - especially
in those patients which remained negative in diagnos-
tics – suggests that HIV-1 may cause the gastrointestinal
damage and the resulting diarrhoea. Further research with
cell culture based techniques is needed to reveal the role
of HIV-1 in gastrointestinal disease.
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